SIMONE, Angela
 Distribuzione geografica
Continente #
NA - Nord America 1.181
EU - Europa 910
AS - Asia 188
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.283
Nazione #
US - Stati Uniti d'America 1.177
IE - Irlanda 276
SE - Svezia 259
CN - Cina 167
IT - Italia 80
UA - Ucraina 70
DE - Germania 49
GB - Regno Unito 49
FI - Finlandia 41
BE - Belgio 26
PL - Polonia 24
AT - Austria 22
IN - India 15
RU - Federazione Russa 10
CA - Canada 4
FR - Francia 4
VN - Vietnam 4
AU - Australia 1
EG - Egitto 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
NZ - Nuova Zelanda 1
Totale 2.283
Città #
Chandler 306
Dublin 275
Jacksonville 151
Nyköping 135
Ann Arbor 77
Beijing 73
Ashburn 71
New York 45
Medford 41
Princeton 41
Cambridge 38
Dearborn 33
Des Moines 31
Brussels 26
Boardman 24
Warsaw 24
Vienna 22
Lancaster 21
Messina 14
Jinan 12
Woodbridge 12
Haikou 11
Pune 11
Nanjing 9
Wilmington 9
Hangzhou 8
Bremen 7
Ningbo 7
Shenyang 7
Hebei 6
Tianjin 6
Genova 5
San Mateo 5
Washington 5
Dong Ket 4
Auburn Hills 3
Changsha 3
Clearwater 3
Jiaxing 3
Redwood City 3
Rome 3
Taiyuan 3
Zhengzhou 3
Catanzaro 2
Fuzhou 2
Guangzhou 2
Helsinki 2
Kemerovo 2
Leawood 2
Saint Petersburg 2
Taizhou 2
Ardabil 1
Augusta 1
Cairo 1
Dunedin 1
Fredericton 1
Hefei 1
Henderson 1
Ivry-sur-Seine 1
Lanzhou 1
Lappeenranta 1
Longueuil 1
Lucan 1
Lucera 1
Meieki 1
Melbourne 1
Mumbai 1
Nanchang 1
Nanning 1
Naples 1
Norwalk 1
Novokuznetsk 1
Ottawa 1
Riva 1
Saint Louis 1
Tomsk 1
Toronto 1
Torregrotta 1
Totale 1.639
Nome #
Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening 85
Detection and genotyping of human papillomavirus in gynaecologic outpatients of Messina, eastern Sicily, Italy. 79
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 74
HER-2 overexpression in advanced node-positive gastric carcinomas: is there any relationship with other clinico-pathological histoprognostic parameters? 74
BRAF mutation testing on melanoma brain metastases 72
Relationship between the presence of high risk HPV DNA and proliferation rate in cervical intraepithelial neoplasia 71
Lactoferrin expression in colorectal cancer: relationships with proliferation indices and survival. 70
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas 67
Immunohistochemical evidence of metallothionein in neoplasms of liver, gallbladder and pancreas 66
Immunohistochemical study of HER-2 overexpression in indolent gastric carcinomas. 65
An immunohistochemical investigation of pre-metastatic niche (PMN) in node-negative invasive breast carcinomas 64
BRAF mutation testing on melanoma brain metastases 63
Human papillomavirus typing in gynaecologic outpatients in Messina, Italy. 60
Analysis of genomic low copy number DNA from cells harvested by laser-microdissection 59
HER2 analysis in sporadic thyroid cancer of follicular cell origin 58
Human Papillomavirus Types Distribution in Eastern Sicilian Females with cervical lesions. A Correlation with Colposcopic and Histological Findings. 57
Clearance and persistence of human papillomavirus infections in patients with lesions of the cervix 56
Immunohistochemical evidence of lactoferrin in human adult normal and neoplastic cartilage 55
KRAS mutation testing on endoscopic biopsy of primary colorectal cancer 55
Immunoexpression of cyclooxygenase (COX)-2 in long-standing ulcerative colitis. 55
Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules 54
Immunohistochemical expression of metallothionein in primary hepatocellular carcinoma and liver metastases 52
Extended RAS mutation testing on wild-type KRAS exon 2 metastatic colorectal cancer. 51
Heterogeneity of KRAS mutational status in colorectal adenocarcinomas with a mucinous component 51
Immunolocalization of lactoferrin in human bone tumours: an investigation by monoclonal antiserum. 50
IMMUNOLOCALIZATION OF LACTOFERRIN IN HUMAN SPORADIC RENAL CELL CARCINOMAS: AN INVESTIGATION BY MONO- AND POLYCLONAL ANTISERA. 50
Heterogeneity of K-Ras mutation status in colorectal adenocarcinomas with a mucinous component. 49
Expression of lactoferrin mRNA in human breast cancer cells selected by laser-microdissection. 49
Laser microdissection and DNA typing of cells from single hair follicles 47
Single sperm cell isolation by laser microdissection 44
Lactoferrin immunoexpression in endometrial carcinomas: Relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival 43
KRAS mutation testing on different areas of primary colorectal adenocarcinomas with mucinous component 42
Risk evaluation in breast cancer: a preliminary study of pre-metastatic niche in 252 negative lymphnodes. 42
Her-2 expression in differentiated thyroid carcinoma (DTC): an immunohistochemical characterization in view of targeted therapies 40
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy 39
Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormone-secreting adrenal phaeochromocytoma: review of the literature and report of a case 37
MGMT promoter methylation status in different portions of surgically resected glioblastomas 37
Immunohistochemical expression of somatostatin receptors sst2A in human meningiomas: is there any relevance with clinico-pathological parameters ? 35
RAS testing in colorectal carcinoma: experience from a single institution of eastern Sicily 32
Liquid biopsy in non-small cell lung cancer: a comparison between different methodologies to detect somatic mutations 32
Molecular analysis of genomic low copy number DNA exracted from laser-microdissected cells. 31
null 31
Immunohistochemical expression of HER2 in thyroid cancer. 29
null 18
null 15
Totale 2.305
Categoria #
all - tutte 7.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.776


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 2 2 4
2019/2020301 42 17 4 14 15 34 30 38 6 60 36 5
2020/2021298 29 8 53 41 30 21 9 15 6 48 23 15
2021/2022350 6 63 6 18 5 6 16 10 6 77 37 100
2022/2023956 66 92 35 113 67 112 16 48 376 5 16 10
2023/2024220 25 29 10 25 23 89 8 8 1 2 0 0
Totale 2.305